Skip to content

Assembly Biosciences, Inc.: 10-K filed 2013-03-18

What Assembly Biosciences, Inc. reported in its annual report filed 2013-03-18 (fiscal FY 2012): 24 published measures, 88 facts as tagged in accession 0001144204-13-015576.

This filing

Form
10-K (annual report)
Filed
2013-03-18
Fiscal period
fiscal FY 2012
Accession
0001144204-13-015576 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Assembly Biosciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3120,555,644USD
At 2011-12-3137,045,781USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-312,745,458USD
At 2011-12-312,513,074USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3117,810,186USD
At 2011-12-3134,532,707USD
At 2010-12-3111,626,116USD
At 2009-12-31-13,362,648USD
At 2008-12-31-9,457,050USD
At 2007-12-31-4,382,043USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3120,489,219USD
At 2011-12-3136,975,434USD
At 2010-12-3114,571,055USD
At 2009-12-3181,288USD
At 2005-10-060USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-3,791,109USD92
2012-01-01 to 2012-12-31-24,790,430USD366
2005-10-07 to 2012-12-31-92,319,514USD2643
2012-07-01 to 2012-09-30-5,355,397USD92
2012-04-01 to 2012-06-30-7,470,048USD91
2012-01-01 to 2012-03-31-8,173,876USD91
2011-10-01 to 2011-12-31-18,859,360USD92
2011-01-01 to 2011-12-31-34,344,730USD365
2011-07-01 to 2011-09-30-5,801,381USD92
2011-04-01 to 2011-06-30-6,961,511USD91
2011-01-01 to 2011-03-31-2,722,478USD90
2010-01-01 to 2010-12-31-15,290,625USD365
2009-01-01 to 2009-12-31-4,539,405USD365
2008-01-01 to 2008-12-31-8,786,430USD366
2007-01-01 to 2007-12-31-4,567,894USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-21,379,790USD366
2005-10-07 to 2012-12-31-61,818,090USD2643
2011-01-01 to 2011-12-31-25,068,832USD365
2010-01-01 to 2010-12-31-5,214,427USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,241USD366
2005-10-07 to 2012-12-3142,464USD2643
2011-01-01 to 2011-12-3111,964USD365
2010-01-01 to 2010-12-310USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,896,816USD366
2005-10-07 to 2012-12-3182,349,773USD2643
2011-01-01 to 2011-12-3147,485,175USD365
2010-01-01 to 2010-12-3119,704,194USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-3,241USD366
2005-10-07 to 2012-12-31-42,464USD2643
2011-01-01 to 2011-12-31-11,964USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-316,841USD
At 2011-12-318,218USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-312,831,651USD366
2005-10-07 to 2012-12-318,771,922USD2643
2011-01-01 to 2011-12-312,982,949USD365
2010-01-01 to 2010-12-312,356,087USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-24,855,496USD366
2005-10-07 to 2012-12-31-78,629,807USD2643
2011-01-01 to 2011-12-31-34,002,073USD365
2010-01-01 to 2010-12-31-4,766,256USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3120,548,803USD
At 2011-12-3137,037,563USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-311,847,245USD
At 2011-12-312,342,074USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-3119,514,163USD366
2005-10-07 to 2012-12-3159,043,406USD2643
2011-01-01 to 2011-12-3125,277,682USD365
2010-01-01 to 2010-12-311,850,666USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3112,934,350shares
At 2011-12-3112,406,406shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-12-31110,116,766USD
At 2011-12-31102,049,385USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-3133,050USD
At 2011-12-3128,432USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-31898,213USD
At 2011-12-31171,000USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-310USD
At 2011-12-310USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-01-01 to 2012-12-315,341,333USD366
2005-10-07 to 2012-12-3119,586,401USD2643
2011-01-01 to 2011-12-318,724,391USD365
2010-01-01 to 2010-12-312,915,590USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,618USD366
2005-10-07 to 2012-12-3135,623USD2643
2011-01-01 to 2011-12-313,746USD365
2010-01-01 to 2010-12-3112,525USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-01-01 to 2012-12-3165,066USD366
2005-10-07 to 2012-12-31-13,689,707USD2643
2011-01-01 to 2011-12-31-342,657USD365
2010-01-01 to 2010-12-31-10,524,369USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-17 to 2013-02-072,044,500USD22
2013-01-18 to 2013-02-0418,710,000USD18
2012-05-01 to 2012-06-304,166,000USD61

Inspect the source

Entity
Assembly Biosciences, Inc. / CIK 0001426800
Captured
2026-09-20T08:03:55.156Z
SEC response SHA-256
f87ee3d44f43bd73d30c280e8d97b2de4bcc4d8a35b03fbebb0e715c83069335

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001426800.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))